Drug Profile
Research programme: interferon therapy - Schering-Plough/Human Genome Sciences
Alternative Names: Interferon therapy research programme - Schering-Plough/Human Genome SciencesLatest Information Update: 18 Jul 2002
Price :
$50
*
At a glance
- Originator Human Genome Sciences
- Developer Human Genome Sciences; Schering-Plough
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Cancer; Rheumatoid arthritis
Most Recent Events
- 16 Oct 2000 New profile
- 16 Oct 2000 Preclinical development for Autoimmune disorders in USA (Unknown route)
- 16 Oct 2000 Preclinical development for Cancer in USA (Unknown route)